A new ferrochelatase mutation combined with low expression alleles in a Japanese patient with erythropoietic protoporphyria.

نویسندگان

  • Yumiko Yasui
  • Shikibu Muranaka
  • Tsuyoshi Tahara
  • Ryo Shimizu
  • Sonoko Watanabe
  • Yutaka Horie
  • Eiji Nanba
  • Hiroshi Uezato
  • Atsushi Takamiyagi
  • Shigeru Taketani
  • Reiko Akagi
چکیده

We investigated the molecular defect of the ferrochelatase gene in a Japanese patient with erythropoietic protoporphyria (EPP), and identified a novel 16 base pair (574-589) deletion within exon 5. This deletion resulted in a frame-shift mutation and created a premature stop codon at amino acid position 198. The same molecular defect was also identified in his mother and a brother who had symptomatic EPP, but not in his father who was asymptomatic. The subjects with EPP were homozygous for the low expression haplotype, while his father was heterozygous for this haplotype. These results indicate that the combination of a 16 base pair deletion and low expression of the wild-type allelic variant is responsible for EPP in this pedigree.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The 6-year follow-up of a Japanese patient with silent erythropoietic protoporphyria

EPP: erythropoietic protoporphyria FECH: ferrochelatase iEPP: incomplete erythropoietic protoporphyria PP: protoporphyrin INTRODUCTION Erythropoietic protoporphyria (EPP) is an inherited cutaneous porphyria caused by a decreased activity of the enzyme ferrochelatase (FECH). EPP patients are clinically characterized by painful photosensitivity of the skin, with some exhibiting liver failure. The...

متن کامل

Haplotype analysis in determination of the heredity of erythropoietic protoporphyria among Swiss families.

Defects in the human ferrochelatase gene lead to the hereditary disorder of erythropoietic protoporphyria. The clinical expression of this autosomal dominant disorder requires an allelic combination of a disabled mutant allele and a low-expressed nonmutant allele. Unlike most other erythropoietic protoporphyria populations, mutations identified among Swiss erythropoietic protoporphyria families...

متن کامل

Production and characterization of erythropoietic protoporphyric heterodimeric ferrochelatases.

Mutations resulting in diminished activity of the dimeric enzyme ferrochelatase are a prerequisite for the inherited disorder erythropoietic protoporphyria (EPP). Patients with clinical EPP have only 10% to 30% of normal levels of ferrochelatase activity, and although many patients with EPP have one mutant allele and one "low-expression" normal allele, the possibility remains that, for some, lo...

متن کامل

RED CELLS Production and characterization of erythropoietic protoporphyric heterodimeric ferrochelatases

Mutations resulting in diminished activity of the dimeric enzyme ferrochelatase are a prerequisite for the inherited disorder erythropoietic protoporphyria (EPP). Patients with clinical EPP have only 10% to 30% of normal levels of ferrochelatase activity, and although many patients with EPP have one mutant allele and one “low-expression” normal allele, the possibility remains that, for some, lo...

متن کامل

Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation.

Erythropoietic protoporphyria (EPP) is a rare autosomal dominant disorder of heme biosynthesis characterized by partial decrease in ferrochelatase (FECH; EC 4.99.1.1) activity with protoporphyrin overproduction and consequent painful skin photosensitivity and rarely liver disease. EPP is normally inherited in an autosomal dominant pattern with low clinical penetrance; the many different mutatio...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Clinical science

دوره 102 5  شماره 

صفحات  -

تاریخ انتشار 2002